158 related articles for article (PubMed ID: 33769500)
1. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology.
Spaan M; van den Belt-Dusebout AW; Lambalk CB; van Boven HH; Schats R; Kortman M; Broekmans FJM; Laven JSE; van Santbrink EJP; Braat DDM; van der Westerlaken LAJ; Cohlen BJ; Cantineau AEP; Smeenk JMJ; van Rumste MM; Goddijn M; van Golde RJT; Meeuwissen PAM; Hamilton CJCM; Ouwens GM; Gerritsma MA; Schaapveld M; Burger CW; van Leeuwen FE
J Natl Cancer Inst; 2021 Jun; 113(6):699-709. PubMed ID: 33769500
[TBL] [Abstract][Full Text] [Related]
2. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.
van Leeuwen FE; Klip H; Mooij TM; van de Swaluw AM; Lambalk CB; Kortman M; Laven JS; Jansen CA; Helmerhorst FM; Cohlen BJ; Willemsen WN; Smeenk JM; Simons AH; van der Veen F; Evers JL; van Dop PA; Macklon NS; Burger CW
Hum Reprod; 2011 Dec; 26(12):3456-65. PubMed ID: 22031719
[TBL] [Abstract][Full Text] [Related]
3. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study.
Lundberg FE; Johansson ALV; Rodriguez-Wallberg K; Gemzell-Danielsson K; Iliadou AN
Eur J Epidemiol; 2019 Nov; 34(11):1093-1101. PubMed ID: 31377935
[TBL] [Abstract][Full Text] [Related]
4. Melanoma risk after ovarian stimulation for in vitro fertilization.
Spaan M; van den Belt-Dusebout AW; Schaapveld M; Mooij TM; Burger CW; van Leeuwen FE;
Hum Reprod; 2015 May; 30(5):1216-28. PubMed ID: 25743782
[TBL] [Abstract][Full Text] [Related]
5. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.
Rizzuto I; Behrens RF; Smith LA
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008215. PubMed ID: 23943232
[TBL] [Abstract][Full Text] [Related]
6. Risk of cancer in children and young adults conceived by assisted reproductive technology.
Spaan M; van den Belt-Dusebout AW; van den Heuvel-Eibrink MM; Hauptmann M; Lambalk CB; Burger CW; van Leeuwen FE;
Hum Reprod; 2019 Apr; 34(4):740-750. PubMed ID: 30715305
[TBL] [Abstract][Full Text] [Related]
7. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study.
Vassard D; Schmidt L; Glazer CH; Lyng Forman J; Kamper-Jørgensen M; Pinborg A
Hum Reprod; 2019 Nov; 34(11):2290-2296. PubMed ID: 31600391
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.
Buis CC; van Leeuwen FE; Mooij TM; Burger CW;
Hum Reprod; 2013 Dec; 28(12):3358-69. PubMed ID: 24014607
[TBL] [Abstract][Full Text] [Related]
9. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract][Full Text] [Related]
10. Cancer in women after assisted reproductive technology.
Luke B; Brown MB; Spector LG; Missmer SA; Leach RE; Williams M; Koch L; Smith Y; Stern JE; Ball GD; Schymura MJ
Fertil Steril; 2015 Nov; 104(5):1218-26. PubMed ID: 26271227
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk among parous women following assisted reproductive technology.
Reigstad MM; Larsen IK; Myklebust TÅ; Robsahm TE; Oldereid NB; Omland AK; Vangen S; Brinton LA; Storeng R
Hum Reprod; 2015 Aug; 30(8):1952-63. PubMed ID: 26113657
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
13. [Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours].
Fortin A; Hazout A; Thoury A; Alvès K; Bats AS; Dhainaut C; Madelenat P
Gynecol Obstet Fertil; 2005; 33(7-8):488-97. PubMed ID: 16019249
[TBL] [Abstract][Full Text] [Related]
14. Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
van den Belt-Dusebout AW; Spaan M; Lambalk CB; Kortman M; Laven JS; van Santbrink EJ; van der Westerlaken LA; Cohlen BJ; Braat DD; Smeenk JM; Land JA; Goddijn M; van Golde RJ; van Rumste MM; Schats R; Józwiak K; Hauptmann M; Rookus MA; Burger CW; van Leeuwen FE
JAMA; 2016 Jul; 316(3):300-12. PubMed ID: 27434442
[TBL] [Abstract][Full Text] [Related]
15. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
[TBL] [Abstract][Full Text] [Related]
16. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
17. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study.
Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
Fertil Steril; 2021 Jan; 115(1):157-163. PubMed ID: 32977941
[TBL] [Abstract][Full Text] [Related]
18. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
19. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C
BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065
[TBL] [Abstract][Full Text] [Related]
20. Risk of Colorectal Cancer After Ovarian Stimulation for In Vitro Fertilization.
Spaan M; van den Belt-Dusebout AW; Burger CW; van Leeuwen FE;
Clin Gastroenterol Hepatol; 2016 May; 14(5):729-37.e5. PubMed ID: 26687912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
